Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: EXC position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on EXC, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 3,976,576 EXC shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 3,976,576 shares
    Change vs previous 13F +213,195 shares

    3.4% of the 13F portfolio, value $185,387,973.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 3,763,381 shares
    Change vs previous 13F +78,901 shares

    3.55% of the 13F portfolio, value $184,480,937.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 3,684,480 shares
    Change vs previous 13F +126,948 shares

    3.37% of the 13F portfolio, value $160,618,525.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 3,557,532 shares
    Change vs previous 13F +3,554,891 shares

    3.59% of the 13F portfolio, value $160,136,596.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 2,641 shares
    Change vs previous 13F +1,898 shares

    <0.01% of the 13F portfolio, value $114,681.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 743 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $34,240.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).